Main Properties of Plinest Hair
Polynucleotides:
1. Stimulate the proliferation of fibroblasts, which leads to an increase in collagen synthesis by 60%.
2. Enhance angiogenesis (the formation of new blood vessels), which leads to improved oxygenation and tissue trophism.
3. Activate the synthesis of fibronectin by 37% - one of the key adhesive proteins of the intercellular matrix, which has the properties of a "molecular glue" that strengthens the tissue.
4. Protect cell DNA from damage caused by UV radiation. PDRNs are a trap for free radicals.
5. Polynucleotides realize their effect through their effect on adenosine A2A receptors. Their activation triggers a wide range of responses that can be broadly classified as anti-inflammatory.
And, as you know, many age-related or pathological processes are associated with chronic inflammation. The regenerative properties of polynucleotides compared to those of hyaluronic acid were also studied. PDRN has been found to be significantly superior to HA in terms of repair properties. Unlike the usual hyaluronic acid, polynucleotides are more effective in fighting the signs of chrono- and photoaging, eliminating wrinkles and sagging. They also correct scars and stretch marks, and are indispensable in the treatment of alopecia. At the same time, their effectiveness has been proven by clinical trials and is based on the principles of evidence-based medicine.
Testimony
Treatment of androgenetic alopecia in men and women, hormonal and age-related alopecia, diffuse and focal alopecia, hair growth disorders after trichological surgery, decreased density and density of hair.
Composition
Polynucleotides 15 mg/2ml
Efficacy & Benefits
Cessation or reduction of the intensity of hair loss. Strengthening of hair, intensification of hair growth. Improvement of hair structure, thickness and shine. The effect is increased when combined with plasma therapy
Contraindications
Individual intolerance to components, pregnancy and lactation, epilepsy, mental disorders, hypertension in the stage of decompensation, autoimmune diseases in the stage of decompensation, infectious (viral and bacterial) diseases in the stage of exacerbation. Oncological diseases - after consultation with the attending physician.